TRIDENT LIFELINE
|
The Current P/S Ratio of TRIDENT LIFELINE is 3.35.
| Share Price | ₹260.2 | Jul 07,2026 |
| Market Cap | ₹309.6 Cr | |
| Sales-TTM | ₹92.5 Cr | TTM-Consolidated Results |
| Price/Sales | 3.35x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of TRIDENT LIFELINE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹309.6 Cr] as on Jul 07,2026
(/) Sales [ ₹92.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.35x ]
Thus, for TRIDENT LIFELINE , the investors are currently willing to pay '3.35 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of TRIDENT LIFELINE !
The chart below summarizes the trend in P/S Ratio of TRIDENT LIFELINE over the last five years.
Historical PS (Price/Sales) ratio chart of TRIDENT LIFELINE
PS Ratio Performance Analysis for TRIDENT LIFELINE
- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 3.35x.
- TRIDENT LIFELINE 's operated at median p/e ratio of 4.22x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 5.77x.
- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does TRIDENT LIFELINE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| TRIDENT LIFELINE | 92.5 | 3.35 | 309.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.81 | 456,593.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 17.02 | 179,737.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.75 | 164,290.0 |
| CIPLA LTD | 28,162.6 | 4.17 | 117,327.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.35 | 112,994.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.32 | 104,550.0 |
| LUPIN LTD | 27,958.0 | 4.07 | 113,844.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.24 | 115,002.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.71 | 91,082.3 |
| LAURUS LABS LTD | 6,812.9 | 11.71 | 79,784.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TRIDENT LIFELINE 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.71x |
| Max industry PS | 17.02x |
| Median industry PS | 4.24x |
| Average industry PS | 7.05x |
You may also like the below Video Courses